NHEK, JNK activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | JNK phosphorylation |
| NHEK-0029 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | JNK phosphorylation | Western blot | IL-17 / OSM / TNF- alpha | |
NHEK, JNK activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | JNK phosphorylation |
| NHEK-0031 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | JNK phosphorylation | Flow cytometry (CBA) | IL-17 / OSM / TNF- alpha | |
NHEK, NF kappaB translocation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | NF kappaB translocation |
| NHEK-0014 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | NF kappaB translocation | Immunofluorescence | IL-17 / OSM / TNF- alpha | |
NHEK, NF kappaB translocation (TNF- alpha stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | NF kappaB translocation |
| NHEK-0015 | Psoriasis, Atopic dermatitis, Psoriasis, Atopic dermatitis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | NF kappaB translocation | Immunofluorescence | TNF- alpha | |
NHEK, STAT1 activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | STAT1 phosphorylation |
| NHEK-0016 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | STAT1 phosphorylation | Western blot | IL-17 / OSM / TNF- alpha | |
NHEK, STAT1 activation (OSM stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | STAT1 phosphorylation |
| NHEK-0017 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | STAT1 phosphorylation | Western blot | Oncostatin M | |
NHEK, STAT1 activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | STAT1 phosphorylation |
| NHEK-0018 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | STAT1 phosphorylation | Flow cytometry (CBA) | IL-17 / OSM / TNF- alpha | |
NHEK, STAT3 activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | STAT3 phosphorylation |
| NHEK-0019 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | STAT3 phosphorylation | Western blot | IL-17 / OSM / TNF- alpha | |
NHEK, STAT3 activation (OSM stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | STAT3 phosphorylation |
| NHEK-0020 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | STAT3 phosphorylation | Western blot | Oncostatin M | |
NHEK, STAT3 activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | STAT3 phosphorylation |
| NHEK-0021 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | STAT3 phosphorylation | Flow cytometry (CBA) | IL-17 / OSM / TNF- alpha | |
NHEK, STAT3 activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | STAT3 phosphorylation / translocation |
| NHEK-0022 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | STAT3 phosphorylation / translocation | Immunofluorescence | IL-17 / OSM / TNF- alpha | |
NHEK, STAT3 activation (OSM stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | STAT3 phosphorylation / translocation |
| NHEK-0023 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | STAT3 phosphorylation / translocation | Immunofluorescence | OSM | |
NHEK, p38 activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | p38 phosphorylation |
| NHEK-0024 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | p38 phosphorylation | Western blot | IL-17 / OSM / TNF- alpha | |
NHEK, p38 activation (IL-1 alpha stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | p38 phosphorylation |
| NHEK-0025 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | p38 phosphorylation | Western blot | IL-1 alpha | |
NHEK, p38 activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | p38 phosphorylation |
| NHEK-0026 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | p38 phosphorylation | Flow cytometry (CBA) | IL-17 / OSM / TNF- alpha | |
NHEK, ERK1/2 activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | ERK1/2 phosphorylation |
| NHEK-0027 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | ERK1/2 phosphorylation | Western blot | IL-17 / OSM / TNF- alpha | |
NHEK, ERK1/2 activation (OSM stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | ERK1/2 phosphorylation |
| NHEK-0028 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | ERK1/2 phosphorylation | Western blot | Oncostatin M | |
NHEK, STAT3 activation (OSM stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | STAT3 phosphorylation |
| NHEK-0041 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | STAT3 phosphorylation | Flow cytometry (CBA) | OSM | |
NHEK, ERK1/2 activation (cytokine stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | ERK1/2 phosphorylation |
| NHEK-0042 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | ERK1/2 phosphorylation | Flow cytometry (CBA) | IL-17 / OSM / TNF- alpha | |
NHEK, ERK1/2 activation (OSM stimulation)| Type of assay | Signal transduction | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | ERK1/2 phosphorylation |
| NHEK-0043 | Psoriasis, Psoriasis | Signal transduction | Epidermal keratinocytes (NHEK) | Human | ERK1/2 phosphorylation | Flow cytometry (CBA) | OSM | |